Aims & Scope

Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.

The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible.

The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work.

We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis.

This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare.

Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.

Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles.

Large datasets, techniques, and tools for the community can also be considered under the article format.

We will also publish reviews covering recent literature in emerging and active fields.

The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 10.6

Journal Rank

Year Value
2024 414

Journal Citation Indicator

Year Value
2024 7445

SJR (SCImago Journal Rank)

Year Value
2024 4.028

Quartile

Year Value
2024 Q1

h-index

Year Value
2024 64

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.


Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.


APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 5,460.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.


Quick Facts

Current Factor
10.6
First Published: 2025

SJR (SCImago Journal Rank)

SJR
4.028
First Published: 2024

Quartile

Current Quartile
Q1
First Published: 2024

Similar Journals

Top Journals in Related Fields